-
Yunnan Provincial Administration for Market Supervision Food Safety Supervision and Sampling Information Circular (Issue 52, 2022
Time of Update: 2023-02-02
Recently, the Yunnan Provincial Administration for Market Supervision organized food safety supervision and random inspection, and sampled 836 batches of samples from 8 categories of grain processed p
-
Treatment of stroke: application of anticoagulant drugs
Time of Update: 2022-09-30
【Indications】It is used to prevent venous embolic disease and venous thrombosis after surgery, to prevent coagulation in vitro circulation during hemodialysis treatment, to treat deep vein thrombosis, and to treat acute unstable angina and non-Q-wave myocardial infarction in combination with aspirin.
-
Bristol-Myers Squibb Opdivo and Yervoy are approved in the UK for the treatment of malignant pleural mesothelioma
Time of Update: 2021-08-15
The trial is an open-label, multicenter, randomized phase III trial that compares Opdivo and Yervoy with standard chemotherapy (pemetrexed combined with cisplatin or carboplatin) for patients with previously untreated malignant pleural mesothelioma.
-
Clin Cancer Res: Regorafenib combined with orvizumab in the treatment of microsatellite stable advanced colorectal cancer
Time of Update: 2021-05-08
org/content/27/8/2139" target="_blank" rel="noopener">Regorafenib-Avelumab Combination in Patients with Microsatellite Stable Colorectal Cancer (REGOMUNE): A Single-arm, Open-label, Phase II Trial.
org/content/27/8/2139" target="_blank" rel="noopener">Regorafenib-Avelumab Combination in Patients with Microsatellite Stable Colorectal Cancer (REGOMUNE): A Single-arm, Open-label, Phase II Trial.
-
[good medicine record] two drugs failed to pass, creating a dramatic scene of consistency evaluation; two drugs overtake in a curve, helping anbisheng become the first R & D institution with drug
Time of Update: 2018-07-20
As of July 19, CDE has accepted 247 applications for conformity assessment (calculated by acceptance number, the same below), involving 103 varieties This week (July 13-19), there was a dramatic scene
-
Sanofi / regenerant PCSK9 antibody praluent faces a permanent ban on production and sales
Time of Update: 2017-01-10
Source: biopharmaceutical editor / Jone 2017-1-10 news event on January 5, 2017, because the defendant Sanofi / PCSK9 antibody pratuent of Zaiban infringed the two patents of the plaintiff into repath
-
Maintenance of labeling machine
Time of Update: 2013-12-11
1 Attention of the brush pressing device: the center of the brush is aligned with the label and both sides are symmetrical The brush is perpendicular to the surface of the container The overlapping cl
